Infinata's BioPharm Insight Journalist Awarded Fellowship by Association of Health Care Journalists

Christine Livoti chosen from a record number of applications for fellowships.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Norwood, MA (PRWEB) February 20, 2013

Infinata’s BioPharm Insight™ announced that Senior Reporter Christine Livoti has been awarded an Association of Health Care Journalists (AHCJ) fellowship. The fellowship allows for Ms. Livoti to attend AHCJ's annual Health Journalism conference taking place next month.

BioPharm Insight offers the global biopharmaceutical community a unique combination of business intelligence, independent investigative journalism, market analytics, and key industry contacts.

The 1300-member AHCJ is an independent, nonprofit organization dedicated to advancing public understanding of health care issues. Its mission is to improve the quality, accuracy and visibility of health care reporting, writing and editing. The organization received a record number of fellowships applications this year.

Ms. Livoti is a member of BioPharm Insight's global team of investigative journalists who provide subscribers with a daily stream of proprietary intelligence predicting market-moving events 6-12 months in advance. Free of any conflicts of interest, the independent editorial team breaks daily news on the most important topics in healthcare.

Ms. Livoti is adept at biopharmaceutical industry and business expertise. Prior to BioPharm Insight she worked with NABsys, the Slater Technology Fund and Landmark Ventures. She is Brown University graduate with Bachelor and Master degrees in Biology. Ms. Livoti has published her tissue engineering research. Her coverage areas include diabetes, HIV/HCV, melanoma, sequencing technology, and diagnostics.

Learn how BioPharm Insight can help you find new business opportunities by starting a free trial today.

About BioPharm Insight
BioPharm Insight is the definitive guide to the global biopharma community. BioPharm Insight provides subscribers with an information edge by combining the most comprehensive real-time database of companies, drugs, contacts, M&A and licensing deals, forecasts and clinical trial data with proprietary forward-looking intelligence uncovered by an independent team of investigative journalists months or even years before it breaks in mainstream media. To learn more, visit http://www.biopharminsight.com. Follow BioPharm Insight on LinkedIn and Twitter.

About Infinata, Inc.
Infinata provides personalized technology solutions to turn information into insight. Services include a comprehensive BioPharm Solutions Suite, unique Wealth Prospecting tools and innovative Custom Data Services. Infinata is a part of Mergermarket, a Financial Times Group company and a division of Pearson plc. To learn more, visit http://www.infinata.com.


Contact

Follow us on: Contact's Twitter Contact's LinkedIn